4.4(top 3%)
Impact Factor
5(top 3%)
extended IF
40(top 10%)
H-Index
405
authors
750
papers
8.9K
citations
1.6K
citing journals
8.5K
citing authors

Most Cited Articles of Current Hematologic Malignancy Reports

TitleYearCitations
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies2013177
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases201694
Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia201686
Incidence and Burden of the Myelodysplastic Syndromes201582
Bruton's tyrosine kinase (BTK) inhibitors in clinical trials201480
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update201675
New proteasome inhibitors in myeloma201274
Ibrutinib (PCI-32765), the first BTK (Bruton's tyrosine kinase) inhibitor in clinical trials201368
Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer201667
Targeting BTK in CLL: Beyond Ibrutinib201965
Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors201263
Role of Microenvironment in Resistance to Therapy in AML201562
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease201862
The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis200960
Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis201357
Immunological Consequences of JAK Inhibition: Friend or Foe?201556
Primary CNS lymphoma201455
CD30+ neoplasms of the skin201155
Clinical implications of c-Kit mutations in acute myelogenous leukemia200955
Emerging EZH2 Inhibitors and Their Application in Lymphoma201853
An immune dysregulation in MPN201453
Targeting the microenvironment in acute myeloid leukemia201552
Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes201252
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You201650
Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve?201749